Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor

Published:2024-05 Issue:3 Volume:23 Page:490-498
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Duong Jennifer T^ORCID,Pope Christopher E,Hayden Hillary S,Miller Carson^ORCID,Salipante Stephen J^ORCID,Rowe Steven M,Solomon George M^ORCID,Nichols David^ORCID,Hoffman Lucas R^ORCID,Narkewicz Michael R,Green Nicole^ORCID

Funder

Cystic Fibrosis Foundation

Seattle Children's Research Institute

National Institutes of Health

Publisher

Elsevier BV

Reference41 articles.

1. Cystic fibrosis foundation patient registry annual data report 2021,2021

2. Cirrhosis and other liver disease in cystic fibrosis;Flass;J Cyst Fibros,2013

3. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome;Colombo;Hepatology,2002

4. Natural history of liver disease in cystic fibrosis;Lindblad;Hepatology,1999

5. The intestinal microbiome and paediatric liver disease;Leung;Lancet Gastroenterol Hepatol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP